Alnylam Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Cash & Equivalents	1,490	966.43	812.69	866.39	819.98	496.58	Upgrade
Short-Term Investments	1,234	1,728	1,627	1,326	1,616	1,378	Upgrade
Cash & Short-Term Investments	2,725	2,695	2,439	2,192	2,436	1,874	Upgrade
Cash Growth	-2.00%	10.46%	11.27%	-9.98%	29.94%	22.02%	Upgrade
Accounts Receivable	964.77	405.31	327.79	237.96	198.57	102.41	Upgrade
Other Receivables	-	-	-	-	-	500	Upgrade
Receivables	964.77	405.31	327.79	237.96	198.57	602.41	Upgrade
Inventory	75.38	78.51	89.15	128.96	86.36	75.2	Upgrade
Prepaid Expenses	188.04	116.96	126.38	132.92	88.08	62.77	Upgrade
Total Current Assets	3,953	3,295	2,983	2,692	2,809	2,615	Upgrade
Property, Plant & Equipment	693.14	693.93	725.79	738.63	733.63	706.51	Upgrade
Long-Term Deferred Tax Assets	98.56	116.86	10.1	-	-	-	Upgrade
Other Long-Term Assets	107.15	133.9	111.29	115.48	101.1	85.77	Upgrade
Total Assets	4,852	4,240	3,830	3,546	3,643	3,407	Upgrade
Accounts Payable	117.59	88.42	55.52	98.09	73.43	51.97	Upgrade
Accrued Expenses	1,154	795.16	654.73	513.78	372.33	299.27	Upgrade
Current Portion of Long-Term Debt	115.69	113.02	54.99	40.29	37.08	13.32	Upgrade
Current Portion of Leases	44.76	41.89	41.51	41.97	40.55	36.87	Upgrade
Current Unearned Revenue	2.54	55.48	102.75	42.11	149.48	127.21	Upgrade
Other Current Liabilities	121.25	92.31	58.28	31.68	22.84	56.64	Upgrade
Total Current Liabilities	1,555	1,186	967.79	767.92	695.71	585.27	Upgrade
Long-Term Debt	2,389	2,359	2,343	2,269	1,827	1,250	Upgrade
Long-Term Leases	223.42	229.54	243.1	261.34	281.35	293.04	Upgrade
Long-Term Unearned Revenue	-	-	188.18	193.79	152.36	225.09	Upgrade
Pension & Post-Retirement Benefits	-	-	-	-	-	5.2	Upgrade
Other Long-Term Liabilities	449.43	398.11	308.44	212.58	98.96	32.71	Upgrade
Total Liabilities	4,618	4,173	4,051	3,705	3,055	2,391	Upgrade
Common Stock	1.32	1.29	1.26	1.24	1.2	1.16	Upgrade
Additional Paid-In Capital	7,415	7,388	6,811	6,455	6,058	5,644	Upgrade
Retained Earnings	-7,160	-7,288	-7,010	-6,569	-5,438	-4,585	Upgrade
Comprehensive Income & Other	-21.78	-34.52	-23.38	-44.65	-33.26	-43.62	Upgrade
Shareholders' Equity	233.89	67.09	-220.64	-158.22	588.2	1,016	Upgrade
Total Liabilities & Equity	4,852	4,240	3,830	3,546	3,643	3,407	Upgrade
Total Debt	2,773	2,743	2,683	2,613	2,186	1,593	Upgrade
Net Cash (Debt)	-48.69	-48.92	-243.24	-420.15	249.87	281.67	Upgrade
Net Cash Growth	-	-	-	-	-11.29%	-77.14%	Upgrade
Net Cash Per Share	-0.37	-0.38	-1.95	-3.45	2.11	2.45	Upgrade
Filing Date Shares Outstanding	132.11	129.46	125.95	124.13	120.21	117	Upgrade
Total Common Shares Outstanding	131.79	129.29	125.79	123.93	120.18	116.43	Upgrade
Working Capital	2,397	2,109	2,015	1,924	2,113	2,030	Upgrade
Book Value Per Share	1.77	0.52	-1.75	-1.28	4.89	8.73	Upgrade
Tangible Book Value	233.89	67.09	-220.64	-158.22	588.2	1,016	Upgrade
Tangible Book Value Per Share	1.77	0.52	-1.75	-1.28	4.89	8.73	Upgrade
Land	-	9.08	9.08	9.08	9.08	9.08	Upgrade
Buildings	-	294.51	271.65	269.32	262.64	262.64	Upgrade
Machinery	-	225.2	202.89	173.1	137.86	120.15	Upgrade
Construction In Progress	-	7.67	30.1	14.6	80.75	28.01	Upgrade
Leasehold Improvements	-	236.69	235.41	230.85	152.05	149.51	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.